Literature DB >> 12504446

Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis?

Tohru Minamino, Haruhiro Toko, Kaoru Tateno, Toshio Nagai, Issei Komuro.   

Abstract

Mesh：

Year:  2002        PMID： 12504446     DOI： 10.1016/s0140-6736(02)11977-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Hypoxically preconditioned human peripheral blood mononuclear cells improve blood flow in hindlimb ischemia xenograft model.

Authors:  Tomoaki Kudo; Masayuki Kubo; Shunsaku Katsura; Arata Nishimoto; Koji Ueno; Makoto Samura; Yasuhiko Fujii; Tohru Hosoyama; Kimikazu Hamano
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  Cell therapy for cardiovascular diseases.

Authors:  Kaoru Tateno; Tohru Minamino; Junji Moriya; Akemi Katada; Masataka Yokoyama; Kentaro Miura; Issei Komuro
Journal:  Ann Vasc Dis       Date:  2008-10-24

3.  Autologous peripheral blood-derived mononuclear cells induced by erythropoietin improve critical ischemic limbs.

Authors:  Tamotsu Kanbara; Hirotsugu Kurobe; Takashi Kitaichi; Mikio Sugano; Taisuke Nakayama; Hajime Kinoshita; Takashi Iwase; Masafumi Akaike; Masahiro Abe; Masataka Sata; Toshio Matsumoto; Tetsuya Kitagawa
Journal:  Ann Vasc Dis       Date:  2012-02-15

Review 4.  Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspective.

Authors:  Daniel M Reed; Gabor Foldes; Sian E Harding; Jane A Mitchell
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

5.  Autoperipheral blood mononuclear cell transplantation improved giant ulcers due to chronic arteriosclerosis obliterans.

Authors:  Shinobu Sugihara; Yasutaka Yamamoto; Koichi Matsubara; Katsunori Ishida; Takashi Matsuura; Fumihiro Ando; Go Igawa; Genta Narazaki; Junichiro Miake; Fumihito Tajima; Ryutaro Nishio; Bin Nakayama; Osamu Igawa; Chiaki Shigemasa; Ichiro Hisatome
Journal:  Heart Vessels       Date:  2006-07       Impact factor: 1.814

Review 6.  Therapeutic strategies for cell-based neovascularization in critical limb ischemia.

Authors:  Makoto Samura; Tohru Hosoyama; Yuriko Takeuchi; Koji Ueno; Noriyasu Morikage; Kimikazu Hamano
Journal:  J Transl Med       Date:  2017-02-24       Impact factor: 5.531

7.  Purified CD34+ cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trial.

Authors:  Zhihui Dong; Tianyue Pan; Yuan Fang; Zheng Wei; Shiyang Gu; Gang Fang; Yifan Liu; Yang Luo; Hao Liu; Tiejun Zhang; Meiyu Hu; Daqiao Guo; Xin Xu; Bin Chen; Junhao Jiang; Jue Yang; Zhenyu Shi; Ting Zhu; Yun Shi; Peng Liu; Weiguo Fu
Journal:  EBioMedicine       Date:  2018-08-29       Impact factor: 8.143

8.  Recent progress in therapeutic angiogenesis.

Authors:  Hironori Nakagami; Ryuichi Morishita
Journal:  Int J Biomed Sci       Date:  2007-09

9.  Bone marrow stem cell injection for the treatment of critical limb ischemia.

Authors:  S Shindo
Journal:  J Stem Cells Regen Med       Date:  2007-11-14

10.  Combinatorial Treatment with Apelin-13 Enhances the Therapeutic Efficacy of a Preconditioned Cell-Based Therapy for Peripheral Ischemia.

Authors:  Makoto Samura; Noriyasu Morikage; Kotaro Suehiro; Yuya Tanaka; Tamami Nakamura; Arata Nishimoto; Koji Ueno; Tohru Hosoyama; Kimikazu Hamano
Journal:  Sci Rep       Date:  2016-01-14       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.